A detailed history of Schroder Investment Management Group transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 74,273 shares of JANX stock, worth $3.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,273
Previous 35,181 111.12%
Holding current value
$3.62 Million
Previous $1.47 Million 129.06%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$35.29 - $50.26 $1.38 Million - $1.96 Million
39,092 Added 111.12%
74,273 $3.37 Million
Q2 2024

Aug 12, 2024

BUY
$35.12 - $64.78 $1.24 Million - $2.28 Million
35,181 New
35,181 $1.47 Million

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2.03B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.